Cargando…
Dissecting phenotypic responses of the druggable targetome in cancers
Although a large amount of screening data comprising target genes and/or drugs tested against cancer cell line panels are available, different assay conditions and readouts limit the integrated analysis and batch-to-batch comparison of these data. Here, we systematically produced and analyzed the an...
Autores principales: | Jeong, Euna, Park, Choa, Moon, Sung Ung, Cho, Juyeon, Song, Mee, Ryoo, Seungeun, Gu, Hyejeong, Lee, Yejin, Kim, Wooyoung, Yoon, Sukjoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715751/ https://www.ncbi.nlm.nih.gov/pubmed/31467349 http://dx.doi.org/10.1038/s41598-019-48989-2 |
Ejemplares similares
-
Loss-of-function screens of druggable targetome against cancer stem–like cells
por: Song, Mee, et al.
Publicado: (2017) -
QSurface: fast identification of surface expression markers in cancers
por: Hong, Yourae, et al.
Publicado: (2018) -
Overexpression and Selective Anticancer Efficacy of ENO3 in STK11 Mutant Lung Cancers
por: Park, Choa, et al.
Publicado: (2019) -
Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
por: Jeong, Euna, et al.
Publicado: (2020) -
MicroRNAs and Their Targetomes in Tumor-Immune Communication
por: Cho, Sunglim, et al.
Publicado: (2020)